The U.S. Food and Drug Administration headquarters in White Oak, Maryland, U.S., on Tuesday, Aug. 25, 2020. The FDA is facing controversy after its commissioner, Stephen Hahn, substantially overstated the benefits of an experimental therapy for Covid-19 patients. Photographer: Stefani Reynolds/Bloomberg via Getty Images